Celsa C, Pennisi G, Tulone A, Ciancimino G, et al. Glucagon-like peptide-1 receptor agonist use is associated with a lower risk of major adverse liver-related outcomes: a meta-analysis of observational cohort studies. Gut 2025;74:815-824.
PMID: 40015951